Preventing functional decline in allogeneic bone marrow transplant: the BOOST study

Not Applicable

Completed

• Conditions: Haematological cancer; Cancer - Leukaemia - Acute leukaemia; Blood - Haematological diseases; Cancer - Leukaemia - Chronic leukaemia; Cancer - Lymphoma (non Hodgkin's lymphoma) - High grade lymphoma; Cancer - Myeloma

• Registration Number: ACTRN12618000888268
• Lead Sponsor: Royal Melbourne Hospital

Brief Summary

/A as yet.

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-05-28
• Study Completion: 2019-12-02
• Last Update Posted: 18 October 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 42

Inclusion Criteria

The safety of each participant to participate in exercise will be assessed daily on an individual basis. In order to participate in group exercise on any given day, participant's must fulfil the following safety criteria:
- Vital observations within normal limits as per hospital protocol
- Platelet count greater than or equal to 15 x 10^9/L (resistance exercise can commence when platelet count is 20 or greater)
- Haemoglobin count greater than 80 g/L
- If a participant is in contact isolation, they may participate in group exercise if they wear gloves; if a participant is in respiratory isolation, they may not participate in group exercise.
- Note, as the exercise group takes place on a pressurised ward there is no contraindication to group exercise with low neutrophil count.
- Note, all participants are advised to practice hand hygiene and clean equipment before/after use.

Exclusion Criteria

Severe active psychiatric or cognitive disorder or unable to provide consent; presence of a musculoskeletal co-morbidity preventing exercise.

Study & Design

• Study Type: Interventional
• Study Design: Not specified